Join the Fight Against Securities Fraud: The Schall Law Firm Calls for Shareholder Involvement in Humacyte Inc. Case
The Schall Law Firm Reminds Investors of Class Action Lawsuit Against Humacyte, Inc. Overview LOS ANGELES, CA / ACCESSWIRE / December 20, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Humacyte, Inc. (“Humacyte” or “the Company”) (NASDAQ:HUMA) for violations of 10(b) and 20(a)…